Monthly Archives: May 2020
Q&A: Self-control, choice, fear and desire for normalcy underpin behavior as economy reopens
Consumer behavior expert Kelly Goldsmith, PhD, delves into how conflicting motivations — a desire for normalcy and being safe — will play out as the economy reopens in Nashville and Tennessee. Continue reading
Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
We created an international registry of IBD patients who developed COVID-19. Corticosteroids, but not TNF antagonists, were associated with adverse outcomes. Other risk factors were similar to the general population. Continue reading
COVID-19: Long-term Planning for Procedure-based Specialties During Extended Mitigation and Suppression Strategies
Focusing on gastrointestinal symptoms in COVID-19 is far from enough
The utility of fecal calprotectin in the era of COVID-19 pandemic
Roles of Clinical Pharmacists in Caring for Patients with Inflammatory Bowel Disease during COVID-19
Leadership During Crisis: Lessons and Applications from the COVID-19 Pandemic
Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn’s Disease
Studies are needed to determine the mechanisms of mucosal dysregulation in patients with inflammatory bowel diseases (IBD) and differences in inflammatory responses of patients with ulcerative colitis (UC) vs Crohn’s disease (CD). We used mass cytometr… Continue reading
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
We identified features of cirrhotic or fibrotic liver tissues and tumors that might be used as markers for tumor development or recurrence. Continue reading